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Potential risks and solutions for sharing




Genome data from African population can substantially assist the global effort to identify aetiological genetic
variants, but open access to aggregated genomic data from these populations poses some significant risks of
community- and population- level harms. A recent amendment to National Institutes of Health policy, following
various engagements with predominantly North American scientists, requires that genomic summary results must
be made available openly on the internet without access oversight or controls.
The policy does recognise that some sensitive, identifiable population groups might be harmed by such exposure
of their data, and allows for exemption in these cases. African populations have a very wide and complex genomic
landscape, and because of this diversity, individual African populations may be uniquely re-identified by their
genomic profiles and genome summary data. Given this identifiability, combined with additional vulnerabilities
such as poor access to health care, socioeconomic challenges and the risk of ethnic discrimination, it would be
prudent for the National Institutes of Health to recognise the potential of their current policy for community harms
to Africans; and to exempt all African populations as sensitive or vulnerable populations with regard to the
unregulated exposure of their genome summary data online.
Three risk-mitigating mechanisms for sharing genome summary results from African populations to inform global
genomic health research are proposed here; namely use of the Beacon Protocol developed by the Global Alliance
for Genomics and Health, user access control through the planned African Genome Variation Database, and
regional aggregation of population data to protect individual African populations from re-identification and
associated harms.
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Background
Because of the complexity and depth of African genomes
compared to rest-of-world populations, genome sum-
mary data that include population allele frequencies
from African populations can greatly enhance identifica-
tion of disease-causing and other variants in African as
well as rest-of-world research, and advances in health
genomics research on the African Continent can con-
tribute meaningfully to biomedical research globally [1].
Since 2008, genomic summary results (GSR) had been ar-
chived in controlled-access portions of NIH-designated
data repositories due to concerns that an individual’s inclu-
sion in a group could be ascertained given their whole gen-
ome data [2]. In November 2018, the National Institutes of
Health (NIH) released a statement updating their policy on
management of access to GSR, based on recent workshops
and various engagement mechanisms undertaken in the
USA to explore access options for sharing GSR.
The NIH concluded that respondents in general be-
lieved that benefits of open access to GSR outweigh the
risks. This informed the subsequent NIH requirement
that GSR generated with NIH funding should be made
freely available on the internet with no access restriction
– with the caveat that some sensitive population groups
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could be exempt from this requirement due to a risk of
stigmatisation of specific communities or populations.
This amended policy also applies to research programs
in Africa that are funded by the NIH, and it is important
to review how the policy might affect the protection of
African study participants and their communities, par-
ticularly as it appears that there was no documented en-
gagement with African stakeholders when considering
the amendment of the policy.
According to documented elements of the public en-
gagement process, the NHGRI Workshop on Aggregate
Genomic Data (May 2016), had predominantly North
American attendees and no registered African repre-
sentatives [3]. A “Request for Information” call in 2017
[4] recorded responses from 109 parties (37 of whom
appeared to be users of ExAC and gnomAD databases
who were solicited to respond using standardised text),
of whom 79% were scientific researchers [5] and none
were African [6]. Finally, the GSR access policy was dis-
cussed at a Genomic Variation Program Workshop on
Establishing a Central Resource of Data from Genome
Sequencing Projects (June 2012) [7], which also had no
African representation in speakers or scheduled con-
tent, although the participant list of this workshop is
not available to confirm whether Africans were present.
Main text
It is, however, important to consider the genomic depth
and breadth of African genomes and the consequent ability
to genetically distinguish small populations and communi-
ties from each other, often in approximation of ethnicity or
ancestral lineage [8, 9]. This inherent genomic complexity
of African populations is often disregarded in Caucasian-
centric policies and recommendations, and community or
population-level risks may be overlooked because such re-
identification of specific Caucasian communities using gen-
omic data is unlikely. Current National boundaries in Africa
were arbitrarily defined during colonisation, and multiple
African populations may co-exist in a single Nation, which
in some cases has resulted in tensions between different
population groups.
The ability to fine-map population-level genomic
data to specific communities comes with inherent
community-level risks that have already been experi-
enced by minority Indigenous populations on other
continents – such as the experiences of the Havasupai
Native Americans [10, 11], or the negative implica-
tions of genomic research for the San population in
Southern Africa [12, 13]. History is littered with ex-
amples of opaque, invasive, and often poor quality re-
search that has damaged vulnerable communities [14];
such as the Xavante and Yanomani populations in
Brazil [15, 16], or the Indigenous populations of
Australia and New Zealand [17, 18].
It is notable that three of the respondents to the NIH
“Request for Information” were representing Native
American Tribes, namely the Sault Ste. Marie Tribe of
Chippewa Indians (submitted by Larry Jacques), the
Southcentral Foundation (submitted by Denise A Dil-
lard), and United South and Eastern Tribes Sovereignty
Protection Fund (submitted by Liz Malerba). These
commentaries all included strong recommendations that
any genomic information should be reviewed by Tribal
review boards and/or community representatives before
release. Concerns were expressed that unlimited and in-
definite use of genomic summary data without oversight
is dangerous to the ongoing trust relationship between
Tribal populations and the NIH; that ongoing and future
determination of harms from genomic information col-
lected from tribal populations must be facilitated; and
that NIH program officers and scientific reviewers might
push widespread data sharing in direct contradiction to
tribes’ requirements as sovereign nations [6].
As with Indigenous populations in North America and
Australasia, as well as other sensitive populations across
the globe, full genomic summary data for identifiable Af-
rican populations or communities published online with-
out any oversight could expose these people to a high
risk of discrimination or stigmatisation. As further
variant-phenotype associations are discovered, allele fre-
quencies for these variants can be assayed in different
populations using GSR, and predictions made about trait
prevalence in those populations. The genomic diversity
and distance between different African populations is
sufficiently large, even on a local scale, that genomic
summary data can uniquely identify individual commu-
nities [8, 9] who can be geographically located, and asso-
ciated phenotypes can be ascribed to those specific
communities based on their aggregated allele frequen-
cies. Given known examples of ethnic discrimination,
violence and xenophobia within Africa [19], as well as
unfortunate historical and ongoing misappropriation of
genetic data to publicly denigrate African populations
[20, 21], the open availability of summary genome data
for distinct African ethnic groups may be unethical be-
cause of the untenable risk of harms accruing to those
populations. As such, African populations should all be
regarded as ‘special populations’ for the purposes of the
new NIH policy to ensure they are protected from such
harms, in line with conclusions drawn in that policy that
privacy risks related to broad access to GSR may be
heightened for some study populations. Furthermore,
participants who have provided DNA samples to date
are unlikely to have consented to have their data shared
openly without Access Committee oversight; and specific
consent for aggregate data sharing - with full participant
information about potential harms - is needed from indi-
viduals as well as generally accepted representative
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community organisations before further sharing of these
aggregated data.
Here, we propose a framework for the use of GSR
from African populations that could greatly reduce the
risk to African participants, whilst still facilitating the
general use of African summary genomic data to inform
and advance global research to identify aetiological vari-
ants and contribute to advancing health research. This
framework has three components that provide options
for appropriate levels of summary data use.
Use of GA4GH beacons
In this use case, a researcher seeking to prioritise candi-
date disease-causing variants in another population could
check whether candidate variants have been identified in
African populations, if so, at what frequency, and/or
whether they have been associated with a specific disease
in African populations. The Global Alliance for Genomics
and Health (GA4GH) Beacon protocol [22, 23] allows re-
searchers to make limited queries as to whether a particu-
lar variant has been seen in a particular dataset, thus
encouraging sharing of information without compromis-
ing privacy, with proposed extensions to include queries
of variant-phenotype associations through direct online
access. Query rate limits can be used to restrict abuse of
the system by “walking” across the genome using thou-
sands of queries of the same aggregated dataset, but with-
out restricting ease of access for honest research purposes.
Registered user access through the African genome
variation database
The African Genome Variation Database (AGVD) is under
development as a project of the H3Africa Informatics
Network [24, 25], and aims to be a resource for exploring
African variation data available to registered users.
Regionally-aggregated genomic data summaries – for ex-
ample for North, South, West and East Africa - can be
made available for bona fide researchers who are reviewed
as part the AGVD general administration for registered
users. It is likely that such summaries will provide valuable
allele frequency data for regional groupings without expos-
ing communities or populations to potential harms; and
that a genetic diversity metric such as Fst [26, 27] could de-
termine an aggregation level that provides some granularity
without exposing individual populations or communities.
Access to study population pre-calculated genomic
summary data through applications reviewed by an
access committee
Where requests for summary data cannot be met by the
processes outlined above, applications for population-
specific summary data could be made through an appro-
priately constituted Access Committee, which should
normally already be in place to administer access to
individual-level genotype data where secondary data use
consents are in place. It is likely that only in a small sub-
set of cases would this detail review be required, as bea-
cons and regional summaries should answer many of the
use cases for external researchers. Should the number of
requests become unmanageable for an existing access
committee, a subcommittee could be constituted of indi-
viduals who are qualified to review specifically these re-
quests under the oversight of the main committee.
Where genotype data are submitted to central repositor-
ies such as the European Genome-Phenome Archive
(EGA) [28], access to African genome summary data
might be managed similarly to whole dataset requests in
cases where Beacons or regional aggregated data do not
suffice.
Conclusions
In conclusion, genome summary data from studies of
African populations can substantially enhance ongoing
health research in African and rest-of-world populations,
and ethical and responsible sharing of these data should
be supported. Open and unregulated online exposure of
genome summary data from African populations or
communities, however, may expose these populations to
unacceptable risks and potential harms such as those ex-
perienced by Indigenous and/or minority population
groups to date. Outlined here are three levels of con-
trolled access to genome summary data from African
populations and communities that can harness the bene-
fits of these data for global and local health research,
whilst mitigating the risks and potential harms for the
African participants and communities who provide their
samples and data for genomic research.
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